Skip to main content
SpringerLink
Log in

Aktualisierte Guidelines der ESMO empfehlen Imatinib

  • Pharma Report
  • Gastrointestinale Stromatumoren
  • Published:
best practice onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aktualisierte Guidelines der ESMO empfehlen Imatinib. Best Practice Onkologie 5, 25–26 (2010). https://doi.org/10.1007/BF03359712

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03359712

Search

Navigation